News & Events
IFM in the News: Novartis spurs a second celebration for IFM’s backers
IFM Therapeutics has done it again. Today’s tie-up with Novartis is the group’s second $300m-plus deal with big pharma in as many years – and leaves the possibility open that IFM could repeat the trick a third time.
View the full Evaluate article here.